V. Duchatelle

Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.

J. Tardif, M. Guertin, J. Tanguay, 2013, Journal of the American College of Cardiology.

Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort study

P. Steg, J. Golmard, G. Ducrocq, 2016, European heart journal. Acute cardiovascular care.

Case report: Mechanical mitral prosthetic valve thrombosis in the context of COVID-19 despite effective anticoagulation

Clarisse Jeckelmann, V. Duchatelle, G. Girod, 2022, European heart journal. Case reports.

Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial

J. Tardif, M. Guertin, J. Tanguay, 2016, Journal of the American Heart Association.

Clinical value of drugs targeting inflammation for the management of coronary artery disease.

J. Tardif, E. Kritikou, V. Duchatelle, 2012, The Canadian journal of cardiology.